Comparison of 2, 5, and 20 % O2 on the development of post-thaw human embryos

J Assist Reprod Genet. 2016 Jul;33(7):919-27. doi: 10.1007/s10815-016-0693-5. Epub 2016 Mar 23.

Abstract

Purpose: The objective of this study is to investigate the effect of 2, 5, and 20 % O2 on post-thaw day 3 human embryo culture until blastocyst stage.

Methods: One hundred fifty-five day 3 human embryos were used. One hundred twenty out of 155 embryos were recovered after thawing. Surviving embryos were distributed into 2, 5, or 20 % O2 groups and cultured for 2.5 days. At the end of culture, blastocyst formation was assessed, and then, embryos were collected for RT-qPCR or immunofluorescence analysis.

Results: Using visible blastocoel to define blastocyst formation, 58.7 % (27/46) of surviving day 3 embryos formed blastocyst at 2 % O2, 63.6 % (28/44) at 5 % O2, and 66.7 % (20/30) at 20 % O2. The difference in blastocyst formation rates was not significant. Average blastocyst cell number was 119.44 ± 11.64 at 2 % O2, 142.55 ± 22.47 at 5 % O2, and 97.29 ± 14.87 at 20 % O2. Average apoptotic rate was 4.7 % ± 0.4 % for blastocyst formed at 2 % O2, 3.5 % ± 0.7 % at 5 % O2, and 5.8 % ± 1.1 % at 20 % O2. Apoptosis rate was significantly lower for blastocysts formed at 5 % O2 (p < 0.05). Compared with gene expression levels at 5 % O2, which were arbitrarily set as "1," 20 % O2 is associated with significantly higher expression of BAX (2.14 ± 0.47), G6PD (2.92 ± 1.06), MnSOD (2.87 ± 0.88), and HSP70.1 (8.68 ± 4.19). For all genes tested, no significant differences were found between 2 and 5 % O2.

Conclusion: The result suggests that development of cryopreserved human embryos from day 3 to blastocyst stage benefits from culture at 5 % O2.

Keywords: Apoptosis; Human embryo; Oxygen; PCR; Stress.

MeSH terms

  • Apoptosis / drug effects*
  • Blastocyst / cytology*
  • Blastocyst / drug effects
  • Connexin 43 / genetics
  • Cryopreservation
  • DNA-Binding Proteins / genetics
  • Embryo Culture Techniques / methods*
  • Embryo Transfer / methods*
  • Embryonic Development / drug effects*
  • Female
  • Glucose Transporter Type 1 / genetics
  • Glucosephosphate Dehydrogenase / genetics
  • Humans
  • Infertility, Female
  • Infertility, Male
  • Intracellular Signaling Peptides and Proteins / genetics
  • Male
  • Nuclear Proteins / genetics
  • Oxygen / pharmacology*
  • RNA, Messenger / biosynthesis
  • Superoxide Dismutase / genetics
  • bcl-2-Associated X Protein / genetics

Substances

  • AKAP8L protein, human
  • Connexin 43
  • DNA-Binding Proteins
  • Glucose Transporter Type 1
  • Intracellular Signaling Peptides and Proteins
  • Nuclear Proteins
  • RNA, Messenger
  • SLC2A1 protein, human
  • bcl-2-Associated X Protein
  • Glucosephosphate Dehydrogenase
  • Superoxide Dismutase
  • Oxygen